Sign In
Buy SIEN
$0.174
+0 (+0%)
At Close: May 20, 2024
As Sientra Options Become Less Bullish This Week, Short Sellers Are Moving In
10:25pm, Thursday, 15'th Jun 2023
After Sientra ( US:SIEN ) announced last week that the FDA had approved the company's tissue expander, the shares' put/call ratio remains very favorable this week, and the number of purchases of SIEN
Sientra stock rockets to pace premarket gainers after FDA clearance of tissue expander
08:30am, Friday, 09'th Jun 2023
Shares of Sientra Inc. SIEN, +3.55% skyrocketed 82.3% toward a seven-month high on heavy volume to pace all premarket gainers Friday after the medical aesthetics company after the U.S. Food and Drug A
Why Fast-paced Mover Sientra (SIEN) Is a Great Choice for Value Investors
09:55am, Monday, 05'th Jun 2023
Sientra (SIEN) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still tradin
Despite Fast-paced Momentum, Sientra (SIEN) Is Still a Bargain Stock
09:58am, Thursday, 18'th May 2023
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Sientra (SIEN) could be a great choice. It is one of the several stocks that passed
Sientra, Inc. (SIEN) Q1 2023 Earnings Call Transcript
07:55pm, Thursday, 11'th May 2023
Sientra, Inc. (NASDAQ:SIEN ) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Oliver Bennett - Chief Legal Compliance and CDO Ron Menezes - President and CEO Andy Schmidt
Sientra to Report First Quarter 2023 Financial Results on May 11, 2023
04:05pm, Monday, 01'st May 2023
IRVINE, Calif., May 01, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plas
Sientra (SIEN) Reports Q4 Loss, Misses Revenue Estimates
07:12pm, Thursday, 30'th Mar 2023
Sientra (SIEN) delivered earnings and revenue surprises of -137.50% and 2.46%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Will Sientra (SIEN) Report Negative Earnings Next Week? What You Should Know
11:27am, Thursday, 23'rd Mar 2023
Sientra (SIEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sientra to Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023
08:35am, Monday, 20'th Mar 2023
IRVINE, Calif., March 20, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of pl
10 Top Penny Stocks To Watch With High Short Interest This Week
02:30pm, Tuesday, 31'st Jan 2023
More short squeeze penny stocks to watch before February 2023. The post 10 Top Penny Stocks To Watch With High Short Interest This Week appeared first on Penny Stocks to Buy, Picks, News and Informati
7 Short-Squeeze Stocks to Buy Before They Soar
02:24pm, Monday, 30'th Jan 2023
As much as we may recognize that short sellers perform a valuable service for the equities market, the concept of targeting short-squeeze stocks to buy just to penalize the pessimists carries catharti
Sientra, Inc. (SIEN) Q3 2022 Earnings Call Transcript
08:08pm, Thursday, 10'th Nov 2022
Sientra, Inc. (NASDAQ:SIEN ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Oliver Bennett - SVP, General Counsel & Chief Compliance Officer Ron Menezes - President
Sientra to Report Third Quarter 2022 Financial Results on November 10, 2022
04:05pm, Monday, 31'st Oct 2022
SANTA BARBARA, Calif., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the ar
Sientra, Inc. (SIEN) CEO Ron Menezes on Q2 2022 Results - Earnings Call Transcript
10:55pm, Thursday, 11'th Aug 2022
Sientra, Inc. (NASDAQ:SIEN ) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Oliver Bennett - Senior Vice President, General Counsel & Chief Compliance Officer Ron Men
7 Stocks Due for a Stunning Short Squeeze
11:54am, Tuesday, 09'th Aug 2022
Although the general rule of thumb is to avoid equities with heavy short interest, the new normal has brought with it new paradigms. One of these fresh approaches urges speculators to acquire short-sq
